The Impact of Low Glycemic Index Nutritional Shake on Glucose Regulation in Overweight and Obese Adults
SHAKE
1 other identifier
interventional
46
1 country
1
Brief Summary
Low glycemic index nutritional shakes have clinically shown to improve post-prandial glycemic responses in acute laboratory control studies. However, there is limited information on how replacing meals with low-glycemic index shake could impact glucose regulation in free-living adults consuming their own diets. The present study aims to examine the impact of adding the SP Glucose-Assist shake to the breakfast of non-diabetic overweight and obese adults. Subjects: 40 non-diabetic adults aged 25-65 years and body mass index ranging between 25-39 . Protocol: This is going to be a three-week study that will include a one-week self-selected diet, followed by two weeks of a breakfast supplement shake (standard process glucose assist) or control cereal oat breakfast.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 25, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2025
CompletedStudy Start
First participant enrolled
March 18, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 9, 2026
CompletedFebruary 13, 2026
February 1, 2026
8 months
February 25, 2025
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Glucose response between two breakfasts
The difference between the two breakfasts on the positive integer of the area under the curve for glucose during the 2 hours following breakfast ingestion.
the entire 2 hours of the glycemic test
Insulin responses between the two breakfasts
The difference between the two breakfasts on the positive integer of the area under the curve for insulin; during the 2 hours following breakfast ingestion.
The entire 2 hours period
Glucose réponses during glucose challenge test
Positive integer of the area under the curve for glucose during the 2 hours glycemic test
2 hours post ingestion of the emperimental meal (cereal or ceral + shake)
Insulin responses during the glucemic challenge test
Positive integer of the area under the curve for insulin during the 2-hours glycemic test
2 hour post ingestion of the intervention meal (cereal or cereal + shake)
Secondary Outcomes (7)
Ambulatory glucose profile
total area under the curve during the 2 weeks (14 days) of dietary intervention.
Blood glucagon
0, 30, 60, 90, and 120 minutes of the glycemic test.
Glucagon like peptide 1
0, 30, 60, 90, and 120 minutes of the glycemic test.
Leptin
0, 30, 60, 90, and 120 minutes of the glycemic test.
Adiponectin
0, 30, 60, 90, and 120 minutes of the glycemic test.
- +2 more secondary outcomes
Study Arms (2)
Control: Breakfast with 400 kcal of oat cereal with honey
SHAM COMPARATORExperimental: Breakfast with 200 kcal of oat ceral with honey + 200 kcal of glucose assist shake.
EXPERIMENTALInterventions
consume of 400kcal of oat-based cereal with honey for breakfast
2 weeks of cereal and standard process glucose assist shake as part of breakfast. The diet for the remainder of the day will remain unchanged.
Eligibility Criteria
You may qualify if:
- Body mass index 25-40
- Eating pattern 3 meals a day
- stable weight for the last 2 months (\<5 pounds fluctuation)
- Willing to eat oat cereal for breakfast
- glycated hemoglobin \<7%
You may not qualify if:
- glycated hemoglobin \>7%
- Body mass index ≤25 or ≥ 40
- Night shifting work
- Atypical meal pattern (not three meals a day or intermittent fasting)
- Thyroid medication
- Bariatric surgery
- Habitual strenuous exercise
- Commuting by bicycle
- Eating disorders
- Use of aspirin during the duration of the study
- Intake of Vit C \>60 mg/day during the study
- cancer
- cardiovascular disease
- renal disease
- hepatic disease
- +5 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Arizona State University 850 PBC
Phoenix, Arizona, 85004, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Assistant Dean
Study Record Dates
First Submitted
February 25, 2025
First Posted
March 4, 2025
Study Start
March 18, 2025
Primary Completion
November 14, 2025
Study Completion
February 9, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share